<DOC>
	<DOCNO>NCT01927692</DOCNO>
	<brief_summary>The primary objective study longitudinally profile immunoglobulin level autoantibody level subject myasthenia gravis ( MG ) receive therapeutic plasma exchange ( TPE ) .</brief_summary>
	<brief_title>Therapeutic Plasma Exchange MG</brief_title>
	<detailed_description>This prospective , multi-center , pilot biomarker study subject receive TPE treatment MG. No study medication give . Ten ( 10 ) AChR antibody positive MG subject enrol study 2 site . Of 10 MG subject , 5 may receive chronic TPE . The study period approximately 3 month consist : - Screening/baseline visit , - TPE visit subject undergo clinical evaluation blood draw immunological assay , - End TPE visit information TPE procedure record , clinical measurement perform , blood sample drawn . - Post-TPE period subject undergo clinical evaluation blood draw immunological assay week 1 , week 2 , week 3 , week 6 , week 12 TPE . Study procedures perform outside usual care include optional single-fiber electromyography ( SFEMG ) study , blood draw optional skin biopsy .</detailed_description>
	<mesh_term>Myasthenia Gravis</mesh_term>
	<criteria>capacity understand sign inform consent form 18 year old diagnosis MG base clinical feature detectable serum autoantibody AChR clinical indication use TPE treat MG unable unwilling comply study procedure include multiple venipuncture weigh less 50Kg contraindication treatment TPE ( e.g . clinically significant bleed disorder ) muscle specific tyrosine kinase lowdensity lipoprotein receptorrelated protein 4 ( LRP4 ) antibody positive MG prior current history thymoma thymectomy past 6 month receive rituximab past 12 month another coexist autoimmune disease clinically control may preclude accurate study assessment accord judgment PI current sign symptom severe , progressive , uncontrolled renal , hepatic , hematological , gastrointestinal , endocrine , pulmonary , cardiac , central nervous system disease participate interventional clinical trial novel therapeutic agent past 6 month cognitively impaired , prisoner , otherwise institutionalized time screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>MG</keyword>
</DOC>